Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Diabetes and Metabolism is Scopus-indexed (Q1, CiteScore 8.1), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Masson s.r.l..
Checked against the index lists dated .
ISSN 1262-3636Verify ISSN ↗1878-1780Verify ISSN ↗
Publisher: Elsevier Masson s.r.l.
Cost to publish: About US$4,490 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 32 / 179 | 82nd | Q1 |
| Endocrinology | 25 / 132 | 81st | Q1 |
| Endocrinology, Diabetes and Metabolism | 47 / 250 | 81st | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1996–present, best quartile Q1, CiteScore 8.1.
Diabetes and Metabolism is Q1 in Internal Medicine (rank 32 of 179), Q1 in Endocrinology (rank 25 of 132) and Q1 in Endocrinology, Diabetes and Metabolism (rank 47 of 250), by CiteScore 2025.
Diabetes and Metabolism is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.1, which places it in quartile Q1 at the 82nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.813, quartile Q1, with an H-index of 114.
The publisher lists an article processing charge of about US$4,490 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Diabetes and Metabolism is published by Elsevier Masson s.r.l. Its print ISSN is 1262-3636 and its online ISSN is 1878-1780.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Diabetes and Metabolism has an h-index of 124 and a 2-year mean of 3.71 citations per paper (OpenAlex). Its Scopus CiteScore is 8.1, quartile Q1. On 2-year citations it ranks #36 of 172 Scopus journals in Internal Medicine.
Diabetes and Metabolism published 95 papers in 2025; its busiest recent year was 2017 with 497. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2025–2026), authors are most often from France (34.7%), China (16.8%) and Taiwan (10%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.